SEROLOGICAL EVALUATION OF MELANOMA PATIENTS IN A PHASE-I-II TRIAL OF VACCINIA MELANOMA ONCOLYSATE (VMO) IMMUNOTHERAPY

被引：0
|
作者：
WALLACK, MK [1 ]
BASH, JA [1 ]
MCNALLY, K [1 ]
机构：
[1] MT SINAI MED CTR,MIAMI BEACH,FL 33140
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1985年 / 26卷 / MAR期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：278 / 278
页数：1
相关论文
共 50 条
  • [1] Ten-year analysis of vaccinia melanoma oncolysate(VMO) phase III trial
    Wallack, M. K.
    Berenji, M.
    Alam, K.
    Bartolucci, A. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [2] ACTIVE SPECIFIC IMMUNOTHERAPY WITH VACCINIA MELANOMA ONCOLYSATE
    WALLACK, MK
    SCOGGIN, SD
    SIVANANDHAM, M
    MOUNT SINAI JOURNAL OF MEDICINE, 1992, 59 (03): : 227 - 233
  • [3] EVIDENCE FOR IMMUNOLOGICAL MECHANISMS INVOLVED IN STABILIZATION OF MELANOMA METASTASES IN A PATIENT UNDERGOING ACTIVE IMMUNOTHERAPY WITH VACCINIA MELANOMA ONCOLYSATE (VMO)
    BASH, JA
    BARNAVON, Y
    WALLACK, MK
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1987, : 116 - 116
  • [4] ACTIVE SPECIFIC ADJUVANT IMMUNOTHERAPY WITH VACCINIA MELANOMA ONCOLYSATE
    SCOGGIN, SD
    SIVANANDHAM, M
    SPERRY, RG
    WALLACK, MK
    ANNALS OF PLASTIC SURGERY, 1992, 28 (01) : 108 - 109
  • [5] A PHASE-III RANDOMIZED, DOUBLE-BLIND, MULTIINSTITUTIONAL TRIAL OF VACCINIA MELANOMA ONCOLYSATE-ACTIVE SPECIFIC IMMUNOTHERAPY FOR PATIENTS WITH STAGE-II MELANOMA
    WALLACK, MK
    SIVANANDHAM, M
    BALCH, CM
    URIST, MM
    BLAND, KI
    MURRAY, D
    ROBINSON, WA
    FLAHERTY, LE
    RICHARDS, JM
    BARTOLUCCI, AA
    ROSEN, L
    CANCER, 1995, 75 (01) : 34 - 42
  • [6] PHASE-I STUDY WITH VACCINIA ONCOLYSATE IMMUNOTHERAPY
    WALLACK, MK
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 369 - 369
  • [7] REACTIONS OF MELANOMA PATIENTS TO IMMUNIZATION WITH A VACCINIA VIRUS HUMAN-MELANOMA ONCOLYSATE
    DORE, JF
    PORTOUKALIAN, J
    BERTHIERVERGNES, O
    JACUBOVICH, R
    GENEVE, J
    BAILLY, M
    LEFTHERIOTIS, E
    WEISSBROD, A
    MAYER, M
    BULLETIN DU CANCER, 1990, 77 (09) : 881 - 891
  • [8] LYMPHOCYTE DEPENDENT ANTIBODY (LDA) ACTIVITY AS A PUTATIVE MECHANISM IN PROLONGED DISEASE-FREE SURVIVAL OF MELANOMA PATIENTS TREATED WITH VACCINIA MELANOMA ONCOLYSATE (VMO)
    BASH, JA
    DARNELL, E
    MERRILL, J
    WALLACK, MK
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 410 - 410
  • [9] CELL-MEDIATED IMMUNE-RESPONSES IN MELANOMA PATIENTS UNDERGOING ACTIVE IMMUNOTHERAPY WITH VACCINIA MELANOMA ONCOLYSATES (VMO)
    BASH, JA
    WALLACK, MK
    LEFTHERIOTIS, E
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1986, : 95 - 95
  • [10] DACARBAZINE VINDESINE CISPLATIN IN DISSEMINATED MALIGNANT-MELANOMA - A PHASE-I-II TRIAL
    RINGBORG, U
    JUNGNELIUS, U
    HANSSON, J
    STRANDER, H
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1990, 13 (03): : 214 - 217
12345